Cindy H Chau Selected Research

Cindy H Chau Research Topics

Disease

29	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2005
22	Neoplasms (Cancer) 01/2024 - 02/2005
6	Hypoxia (Hypoxemia) 01/2021 - 12/2002
4	Disease Progression 01/2022 - 10/2004
2	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2005
2	Fatigue 01/2021 - 06/2013
2	Multiple Myeloma 10/2019 - 05/2016
2	Keloid 08/2005 - 04/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Obesity 01/2022
1	Cystitis 01/2022
1	Mastodynia 01/2021
1	COVID-19 10/2020
1	Hyperbilirubinemia 10/2019
1	Hypoalbuminemia 10/2019
1	Breast Neoplasms (Breast Cancer) 12/2016
1	Leprosy (Hansen's Disease) 05/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Diarrhea 11/2014

Drug/Important Bio-Agent (IBA)

9	AndrogensIBA 01/2022 - 02/2005
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2016
7	enzalutamideIBA 12/2022 - 06/2015
7	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 02/2005
4	Finasteride (Propecia)FDA LinkGeneric 01/2022 - 12/2010
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2021
3	olaparibIBA 04/2021 - 01/2021
3	rucaparibIBA 04/2021 - 01/2021
3	Testosterone (Sustanon)FDA Link 01/2021 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 06/2015 - 04/2004
3	Docetaxel (Taxotere)FDA Link 09/2013 - 07/2012
2	Tumor Biomarkers (Tumor Markers)IBA 01/2024 - 12/2016
2	Ligases (Synthetase)IBA 01/2023 - 01/2021
2	Topoisomerase I InhibitorsIBA 01/2023 - 01/2022
2	SteroidsIBA 01/2022 - 01/2016
2	IT-101IBA 01/2022 - 01/2021
2	CamptothecinIBA 01/2022 - 01/2021
2	Hormones (Hormone)IBA 01/2022 - 01/2016
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 12/2010
2	Androgen Receptor AntagonistsIBA 01/2021 - 01/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 10/2019
2	discorhabdin LIBA 07/2018 - 01/2016
2	discorhabdin HIBA 07/2018 - 01/2016
2	Thalidomide (Thalomid)FDA Link 05/2016 - 10/2015
2	Dihydrotestosterone (Androstanolone)IBA 06/2015 - 02/2005
2	Prednisone (Sone)FDA LinkGeneric 09/2013 - 06/2013
2	Messenger RNA (mRNA)IBA 08/2005 - 04/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2005 - 12/2002
2	Plasminogen Activator Inhibitor 1IBA 08/2005 - 04/2004
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Organic Anion TransportersIBA 01/2024
1	Adenosine Triphosphate (ATP)IBA 01/2024
1	Circulating Tumor DNAIBA 11/2023
1	GenieIBA 02/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023
1	Calcibiotic Root Canal SealerIBA 01/2023
1	pevonedistatIBA 01/2023
1	UbiquitinIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 12/2022
1	Serine Proteases (Serine Protease)IBA 12/2022
1	SolutionsIBA 12/2022
1	Kallikreins (Kallikrein)IBA 12/2022
1	EnzymesIBA 12/2022
1	niraparibIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 11/2021
1	GelatinIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	PROSTVACIBA 01/2021
1	AnionsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	abirateroneIBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2020
1	CytochromesIBA 01/2020
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 01/2020
1	LyasesIBA 01/2020
1	seviteronelIBA 01/2020
1	Lenalidomide (CC 5013)FDA Link 10/2019
1	carfilzomibIBA 10/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2016
1	Trastuzumab (Herceptin)FDA Link 12/2016
1	Aromatase (CYP19)IBA 01/2016
1	LuciferasesIBA 01/2016
1	makaluvamine FIBA 01/2016
1	discorhabdin WIBA 01/2016
1	discorhabdin BIBA 01/2016
1	OF 900IBA 11/2014
1	perifosineIBA 11/2014
1	Cell ExtractsIBA 04/2014
1	satraplatin (JM 216)IBA 09/2013

Therapy/Procedure

14	Castration 01/2024 - 07/2012
14	Therapeutics 12/2022 - 12/2009
2	Immunotherapy 01/2022 - 01/2021
2	Precision Medicine 04/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
1	Prostatectomy (Retropubic Prostatectomy) 01/2024